Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (beta S)-alpha-hydroxy-beta-(((2s)-4-methyl-1-oxo-2-(((phenylmethoxy)carbonyl)amino)pentyl)amino)-2-oxo-3-pyrrolidinepropanesulfonic Acid
2. (beta S)-alpha-hydroxy-beta-(((2s)-4-methyl-1-oxo-2-(((phenylmethoxy)carbonyl)amino)pentyl)amino)-2-oxo-3-pyrrolidinepropanesulfonic Acid (1:1) Sodium Salt
3. Gc 376
4. Gc-376
5. Gc-376 Free Acid
6. Gc376
7. Sodium (2s)-2-((s)-2-(((benzyloxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate
1. 1416992-39-6
2. Gc376
3. Gc-376
4. H1nmj5xdg5
5. Sodium (2s)-2-((s)-2-(((benzyloxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate
6. (betas)-alpha-hydroxy-beta-[[(2s)-4-methyl-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]pentyl]amino]-2-oxo-3-pyrrolidinepropanesulfonic Acid Sodium Salt
7. Sodium;(2s)-1-hydroxy-2-[[(2s)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate
8. Unii-h1nmj5xdg5
9. Chembl2315036
10. Dtxsid001028041
11. At23091
12. Cs-6923
13. As-84675
14. Hy-100721
15. A937086
16. 3-pyrrolidinepropanesulfonic Acid, .alpha.-hydroxy-.beta.-(((2s)-4-methyl-1-oxo-2-(((phenylmethoxy)carbonyl)amino)pentyl)amino)-2-oxo-, Sodium Salt (1:1), (.beta.s)-
17. 3-pyrrolidinepropanesulfonic Acid, Alpha-hydroxy-beta-(((2s)-4-methyl-1-oxo-2-(((phenylmethoxy)carbonyl)amino)pentyl)amino)-2-oxo-, Sodium Salt (1:1), (betas)-
18. Sodium (2s)-1-hydroxy-2-[[(2s)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate
19. Sodium (2s)-2-[(2s)-2-{[(benzyloxy)carbonyl]amino}-4-methylpentanamido]-1-hydroxy-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate
| Molecular Weight | 507.5 g/mol |
|---|---|
| Molecular Formula | C21H30N3NaO8S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 12 |
| Exact Mass | 507.16513038 g/mol |
| Monoisotopic Mass | 507.16513038 g/mol |
| Topological Polar Surface Area | 182 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 783 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Protease Inhibitors
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)
ABOUT THIS PAGE
21
PharmaCompass offers a list of GC376 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right GC376 manufacturer or GC376 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred GC376 manufacturer or GC376 supplier.
PharmaCompass also assists you with knowing the GC376 API Price utilized in the formulation of products. GC376 API Price is not always fixed or binding as the GC376 Price is obtained through a variety of data sources. The GC376 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GC376 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GC376, including repackagers and relabelers. The FDA regulates GC376 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GC376 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GC376 supplier is an individual or a company that provides GC376 active pharmaceutical ingredient (API) or GC376 finished formulations upon request. The GC376 suppliers may include GC376 API manufacturers, exporters, distributors and traders.
GC376 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GC376 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GC376 GMP manufacturer or GC376 GMP API supplier for your needs.
A GC376 CoA (Certificate of Analysis) is a formal document that attests to GC376's compliance with GC376 specifications and serves as a tool for batch-level quality control.
GC376 CoA mostly includes findings from lab analyses of a specific batch. For each GC376 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GC376 may be tested according to a variety of international standards, such as European Pharmacopoeia (GC376 EP), GC376 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GC376 USP).
